Guangzhou Human New Material Science and Technology Co., Ltd. (SHE:301683)
China · Delayed Price · Currency is CNY 99.90
-1.01 (-1.00%)
At close: Aug 3, 2026
SHE:301683 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Operating Revenue | 1,015 | 977.71 | 811.2 | 716.02 | 657.31 |
Other Revenue | 7.47 | 7.47 | 5.71 | 1.36 | 6.29 |
| 1,023 | 985.18 | 816.91 | 717.37 | 663.6 | |
Revenue Growth | 54.11% | 20.60% | 13.88% | 8.10% | - |
Cost of Revenue | 571.23 | 550.45 | 489.95 | 451.63 | 482.7 |
Gross Profit | 451.43 | 434.73 | 326.96 | 265.74 | 180.89 |
Selling, General & Admin | 133.8 | 127.41 | 111.02 | 109.57 | 104.49 |
Research & Development | 71.01 | 68.1 | 54.91 | 50.6 | 47.89 |
Other Operating Expenses | 7.58 | 7.31 | 2.51 | 2.9 | 5 |
Operating Expenses | 213.16 | 202.63 | 171.93 | 166.58 | 156.75 |
Operating Income | 238.26 | 232.11 | 155.03 | 99.16 | 24.15 |
Interest Expense | -0.1 | -0.09 | - | -2.62 | -3.96 |
Interest & Investment Income | 4.75 | 3.98 | 4.28 | 10.5 | 2.79 |
Currency Exchange Gain (Loss) | -0.06 | -0.06 | 0.26 | 0.07 | 0.3 |
Other Non Operating Income (Expenses) | -0.5 | -0.19 | 1.28 | -0.18 | 0.14 |
EBT Excluding Unusual Items | 242.36 | 235.75 | 160.85 | 106.93 | 23.41 |
Gain (Loss) on Sale of Investments | -0.04 | - | - | 0.91 | 0.62 |
Gain (Loss) on Sale of Assets | -0.04 | -0.04 | 0.37 | 5.08 | 0.05 |
Asset Writedown | -1.12 | -0.21 | -0.3 | -0.79 | -0.14 |
Other Unusual Items | 1.31 | 1.51 | 3.72 | 4.15 | 3.1 |
Pretax Income | 242.48 | 237.01 | 164.64 | 116.28 | 27.05 |
Income Tax Expense | 31.2 | 30.22 | 18.85 | 10.65 | 1.1 |
Earnings From Continuing Operations | 211.29 | 206.79 | 145.79 | 105.63 | 25.95 |
Minority Interest in Earnings | - | - | - | 2.93 | 4.14 |
Net Income | 211.29 | 206.79 | 145.79 | 108.56 | 30.09 |
Net Income to Common | 211.29 | 206.79 | 145.79 | 108.56 | 30.09 |
Net Income Growth | 602.14% | 41.84% | 34.29% | 260.77% | - |
Shares Outstanding (Basic) | 47 | 47 | 47 | 46 | - |
Shares Outstanding (Diluted) | 47 | 47 | 47 | 46 | - |
Shares Change | - | -0.03% | 3.33% | - | - |
EPS (Basic) | 4.47 | 4.37 | 3.08 | 2.37 | - |
EPS (Diluted) | 4.47 | 4.37 | 3.08 | 2.37 | - |
EPS Growth | - | 41.88% | 29.96% | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Free Cash Flow | 61.05 | 98.07 | 68.74 | 87.53 | 10.95 |
Free Cash Flow Per Share | 1.29 | 2.07 | 1.45 | 1.91 | - |
Dividend Per Share | 1.100 | 1.100 | 0.730 | - | - |
Dividend Growth | - | 50.69% | - | - | - |
Gross Margin | 44.14% | 44.13% | 40.02% | 37.04% | 27.26% |
Operating Margin | 23.30% | 23.56% | 18.98% | 13.82% | 3.64% |
Profit Margin | 20.66% | 20.99% | 17.85% | 15.13% | 4.54% |
Free Cash Flow Margin | 5.97% | 9.95% | 8.41% | 12.20% | 1.65% |
EBITDA | 265.02 | 258.48 | 179.88 | 123.87 | 48.36 |
EBITDA Margin | 25.91% | 26.24% | 22.02% | 17.27% | 7.29% |
D&A For EBITDA | 26.76 | 26.37 | 24.85 | 24.7 | 24.22 |
EBIT | 238.26 | 232.11 | 155.03 | 99.16 | 24.15 |
EBIT Margin | 23.30% | 23.56% | 18.98% | 13.82% | 3.64% |
Effective Tax Rate | 12.86% | 12.75% | 11.45% | 9.16% | 4.05% |
Revenue as Reported | 1,023 | 985.18 | 816.91 | - | - |